• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Threadneedle UK Eq Alpha Inc RDR Z Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Columbia Threadneedle
Fund Summary The aim of the Fund is to provide income with the potential to grow the amount you invested. The Fund invests at least two-thirds of its assets in shares of UK companies or companies that have significant operations there. The Funds investment approach means it will typically hold a small number of investments compared with other funds. The Fund may also invest in asset classes and instruments different from those stated above.
SEDOL code B88P6D7
ISIN GB00B88P6D76
Fund code THTIZ
Managers Richard Colwell
Manager Tenure 9 years
Morningstar Category UK Equity Income
IMA Sector UK Equity Income
Fund Size £376 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.88%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.3291
Buy Price £1.3291
Price Change +0.0527%
Price Date 17th May 2019
Yield 4.45%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 8th May 2006
Fund Status OPEN
Richard Colwell is a portfolio manager and Head of UK Equities at Columbia Threadneedle. He manages the Threadneedle UK Growth & Income Fund, Threadneedle UK Equity Income Fund and the Threadneedle UK Equity Alpha Income Fund. He also co-manages the Threadneedle Monthly Extra Income Fund and has research responsibility across all sectors. Before joining the company, Richard ran high alpha UK equity portfolios at Aviva Investors. He has also held portfolio management roles at Credit Suisse and Schroders and worked at the Bank of England. Richard has a degree in Banking, Insurance & Finance from the University of Bangor. He holds the Chartered Financial Analyst designation and is a member of the CFA Society of the UK as well as the Chartered Institute of Bankers.

3-year Mean Monthly Return: 0.580%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance +5.87% -4.93% +15.54% -2.39% +11.37% +19.97% +21.90% +6.90% +11.75% +34.56%
Benchmark Performance
(UK Equity Income)
+0.64% +2.74% +10.25% +1.17% +8.88%
Time Period Cumulative Benchmark Performance
(UK Equity Income)
Fund Compared to Benchmark
1 day 0.05% +0.18% -0.13%
1 week 0.06% +0.82% -0.76%
1 month -1.37% -1.79% +0.42%
3 months -1.53% +2.64% -4.17%
6 months -0.70% +4.81% -5.50%
1 year -2.70% -3.60% +0.90%
3 years 18.16% +21.12% -2.96%
5 years 22.61% +29.21% -6.60%
10 years 174.85% +163.66% +11.19%
YTD 6.21% +10.10% -3.89%
Since inception 139.16% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 8.52%
Imperial Brands PLC GBR 5.80%
GlaxoSmithKline PLC GBR 5.72%
Phoenix Group Holdings PLC GBR 5.40%
Morrison (Wm) Supermarkets PLC GBR 4.78%
Electrocomponents PLC GBR 4.57%
Pearson PLC GBR 4.27%
Legal & General Group PLC GBR 4.18%
Rentokil Initial PLC GBR 3.91%
RSA Insurance Group PLC GBR 3.85%
Dividend Date Per share amount Reinvestment Price
1st May 2019 0.0306 £1.3621
1st November 2018 0.0298 £1.3843
1st May 2018 0.0305 £1.3966
1st November 2017 0.0284 £1.4352
2nd May 2017 0.0328 £1.4437
1st November 2016 0.0284 £1.3562